These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 2981369)

  • 1. Screening test for HTLV-III (AIDS agent) antibodies. Specificity, sensitivity, and applications.
    Weiss SH; Goedert JJ; Sarngadharan MG; Bodner AJ; Gallo RC; Blattner WA
    JAMA; 1985 Jan; 253(2):221-5. PubMed ID: 2981369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of acquired immunodeficiency syndrome (AIDS) retrovirus antibody by lymphadenopathy-associated virus (LAV) enzyme immunoassay in low- and high-risk populations.
    Ragni MV; Lewis JH; Bracken M; Toth R; Stokes J; Steffensen DO
    Transfusion; 1986; 26(3):299-301. PubMed ID: 3010516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HTLV-III infection among health care workers. Association with needle-stick injuries.
    Weiss SH; Saxinger WC; Rechtman D; Grieco MH; Nadler J; Holman S; Ginzburg HM; Groopman JE; Goedert JJ; Markham PD
    JAMA; 1985 Oct; 254(15):2089-93. PubMed ID: 2995694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective study of cytotoxic T lymphocyte responses to influenza and antibodies to human T lymphotropic virus-III in homosexual men. Selective loss of an influenza-specific, human leukocyte antigen-restricted cytotoxic T lymphocyte response in human T lymphotropic virus-III positive individuals with symptoms of acquired immunodeficiency syndrome and in a patient with acquired immunodeficiency syndrome.
    Shearer GM; Salahuddin SZ; Markham PD; Joseph LJ; Payne SM; Kriebel P; Bernstein DC; Biddison WE; Sarngadharan MG; Gallo RC
    J Clin Invest; 1985 Oct; 76(4):1699-704. PubMed ID: 2997287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of antibodies against LAV/HTLV III: comparative evaluation of four different commercial test kits.
    Abb J
    AIDS Res; 1986; 2(2):93-7. PubMed ID: 3013224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HTLV-III AIDS link.
    Bennett JA
    Am J Nurs; 1985 Oct; 85(10):1086-9. PubMed ID: 2996353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Testing for antibodies to AIDS-associated retrovirus (HTLV-III/LAV) by indirect fixed cell immunofluorescence: specificity, sensitivity, and applications.
    Hedenskog M; Dewhurst S; Ludvigsen C; Sinangil F; Rodriguez L; Wu YT; Volsky DJ
    J Med Virol; 1986 Aug; 19(4):325-34. PubMed ID: 3018138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgG-antibodies to HTLV-III in patients with AIDS, LAS, and persons at risk of AIDS in West Germany.
    Hehlmann R; Kreeb G; Erfle V; Piechowiak H; Krüger G; Goebel FD
    Blut; 1985 Jan; 50(1):13-8. PubMed ID: 2981593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to HTLV-III in Swiss patients with AIDS and pre-AIDS and in groups at risk for AIDS.
    Schüpbach J; Haller O; Vogt M; Lüthy R; Joller H; Oelz O; Popovic M; Sarngadharan MG; Gallo RC
    N Engl J Med; 1985 Jan; 312(5):265-70. PubMed ID: 2981407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for AIDS.
    Med Lett Drugs Ther; 1985 Mar; 27(684):29-30. PubMed ID: 2984526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.
    Safai B; Sarngadharan MG; Groopman JE; Arnett K; Popovic M; Sliski A; Schüpbach J; Gallo RC
    Lancet; 1984 Jun; 1(8392):1438-40. PubMed ID: 6145881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of nosocomial infection with human T-cell lymphotropic virus III (HTLV-III).
    Hirsch MS; Wormser GP; Schooley RT; Ho DD; Felsenstein D; Hopkins CC; Joline C; Duncanson F; Sarngadharan MG; Saxinger C
    N Engl J Med; 1985 Jan; 312(1):1-4. PubMed ID: 2981106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
    Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
    Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radioimmunoassay and enzyme-linked immunoassay of antibodies to the core protein (P24) of human T-lymphotropic virus (HTLV III).
    Neurath AR; Strick N; Sproul P; Baker L; Rubinstein P; Stevens CE; Taylor P; Gallo RC; Gold JW; Lee YS
    J Virol Methods; 1985 May; 11(1):75-86. PubMed ID: 2989312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unique pattern of HTLV-III (AIDS-related) antigen recognition by sera from African children in Uganda (1972).
    Saxinger C; Levine PH; Dean A; Lange-Wantzin G; Gallo R
    Cancer Res; 1985 Sep; 45(9 Suppl):4624s-4626s. PubMed ID: 2990697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviruses associated with leukemia and ablative syndromes in animals and in human beings.
    Essex M; McLane MF; Kanki P; Allan J; Kitchen L; Lee TH
    Cancer Res; 1985 Sep; 45(9 Suppl):4534s-4538s. PubMed ID: 2990682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AIDS serology testing in low- and high-risk groups.
    Carlson JR; Bryant ML; Hinrichs SH; Yamamoto JK; Levy NB; Yee J; Higgins J; Levine AM; Holland P; Gardner MB
    JAMA; 1985 Jun; 253(23):3405-8. PubMed ID: 2987558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Counterimmunoelectrophoresis for detection of human serum antibody to HTLV-III.
    Blaser MJ; Cohn DL; Cody HJ; Penley KA; Judson FN; Saxinger WC; Weiss SH
    J Immunol Methods; 1986 Jul; 91(2):181-6. PubMed ID: 3016097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-I and type-III HTLV antibodies in hospitalized and out-patient Zairians.
    Gazzolo L; Robert-Guroff M; Jennings A; Duc Dodon M; Najberg G; Peti MM; de-Thé G
    Int J Cancer; 1985 Sep; 36(3):373-8. PubMed ID: 2993173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.